Clinical Trial Update: A Study of RGX-104 in Patients With Advanced Lung & Endometrial Cancer [Phase 1]

View source ↗

Summary

Phase 1 study of RGX-104 in patients with advanced lung and endometrial cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer
• Non-small Cell Lung Cancer

Drugs mentioned

• RGX-104

Snippet

Sponsor: Inspirna, Inc. | Conditions: Endometrial Cancer, Endometrial Cancer Recurrent | Phase 1 | Status: COMPLETED